Healthcare -
Biotechnology - NYSE - CH
$ 1.635
-7.1 %
$ 158 M
Market Cap
-0.68
P/E
ADCT - CASH & EQUIVALENTS
Cash & Equivalents ADCT - ADC Therapeutics SA
279 M
LAST VALUE
-22.72%
2 YEAR CAGR
14.95%
5 YEAR CAGR
0.00%
10 YEAR CAGR